{"id":2433,"date":"2025-06-09T08:18:40","date_gmt":"2025-06-09T12:18:40","guid":{"rendered":"https:\/\/glycovax.com\/?p=2433"},"modified":"2025-10-07T10:31:28","modified_gmt":"2025-10-07T14:31:28","slug":"glycovax-commercialise-un-crm197-abordable","status":"publish","type":"post","link":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/","title":{"rendered":"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable"},"content":{"rendered":"\n

Montr\u00e9al, Canada, le 9 juin 2025<\/strong> \u2013 Glycovax Pharma Inc. a entrepris la bioproduction \u00e0 grande \u00e9chelle de la prot\u00e9ine porteuse CRM197 qui sera utilis\u00e9e dans de nombreux vaccins conjugu\u00e9s pour les humains et les animaux. Le Conseil national de recherches du Canada (CNRC) a mis au point un syst\u00e8me de production unique et tr\u00e8s efficace pour la CRM197. Glycovax a affin\u00e9 sa production pour r\u00e9pondre aux exigences r\u00e9glementaires \u00e0 des niveaux qui d\u00e9passent les normes de qualit\u00e9 de composantes de vaccin conjugu\u00e9 pour l’administration humaine et animale. Glycovax Pharma commercialisera cette prot\u00e9ine \u00e0 travers sa filiale Espoir Th\u00e9rapeutiques Inc. pour r\u00e9pondre aux besoins des soci\u00e9t\u00e9s de d\u00e9veloppement de vaccins et des centres de recherche du secteur.<\/p>\n\n

Les vaccins \u00e0 base d’hydrates de carbone (glycanes) constituent l’une des innovations m\u00e9dicales les plus importantes du si\u00e8cle dernier, ayant sauv\u00e9 des millions de vies d’infections bact\u00e9riennes dans le monde entier. \u00c0 ce jour, seule une poign\u00e9e de prot\u00e9ines a \u00e9t\u00e9 utilis\u00e9e dans les vaccins conjugu\u00e9s, CRM197 \u00e9tant la plus utilis\u00e9e en raison de ses propri\u00e9t\u00e9s avantageuses. Malgr\u00e9 son r\u00f4le important, la production \u00e0 grande \u00e9chelle de CRM197 \u00e0 co\u00fbt raisonnable a \u00e9t\u00e9 une limitation pour les d\u00e9veloppeurs de vaccins. Glycovax Pharma vise \u00e0 rendre cette prot\u00e9ine plus accessible afin de mieux prot\u00e9ger la sant\u00e9 des populations.<\/p>\n\n

\u00ab Cette entente avec le CNRC marque une \u00e9tape importante pour notre entreprise \u00bb, a d\u00e9clar\u00e9 Dany Valiquette, pr\u00e9sident et chef de la direction de Glycovax Pharma. \u00ab Au cours des prochains mois, nous serons en mesure d’offrir la CRM197 aux d\u00e9veloppeurs de vaccins, qu’il s’agisse d’entreprises pharmaceutiques, biotechnologiques ou d\u2019\u00e9tablissements universitaires de recherche, en leur garantissant un processus de fabrication \u00e0 grande \u00e9chelle, \u00e0 un co\u00fbt raisonnable et conforme aux BPF. Ces d\u00e9veloppeurs auront la possibilit\u00e9 d’\u00e9valuer notre CRM197 avec leurs propres antig\u00e8nes, et Glycovax les accompagnera dans les aspects r\u00e9glementaires du d\u00e9veloppement de leur vaccin. \u00bb<\/p>\n\n

Au sujet de Glycovax Pharma<\/h3>\n\n

Fond\u00e9e \u00e0 Montr\u00e9al, au Canada, en 2016, Glycovax Pharma est une soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans la conception et le d\u00e9veloppement de vaccins glycoconjugu\u00e9s. Gr\u00e2ce \u00e0 son expertise unique en glyco-immunologie, Glycovax Pharma se positionne \u00e0 l\u2019avant-garde de solutions vaccinales plus efficaces, particuli\u00e8rement dans les domaines des infections virales ou bact\u00e9riennes et du cancer. Pour plus d\u2019information, visitez : www.glycovax.com<\/p>\n\n

SOURCE : Glycovax Pharma<\/p>\n\n

Pour information:<\/p>\n\n

Daniel Grangerdaniel.granger@acjcommunication.com<\/a>514 840 7990<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Montr\u00e9al, Canada, le 9 juin 2025 \u2013 Glycovax Pharma Inc. a entrepris la bioproduction \u00e0 grande \u00e9chelle de la prot\u00e9ine porteuse CRM197 qui sera utilis\u00e9e dans de nombreux vaccins conjugu\u00e9s pour les humains et les animaux. Le Conseil national de recherches du Canada (CNRC) a mis au point un syst\u00e8me de production unique et tr\u00e8s…<\/p>\n","protected":false},"author":2,"featured_media":2489,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[96],"tags":[],"class_list":["post-2433","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communiques-de-presse"],"acf":[],"yoast_head":"\nGlycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable - Glycovax Pharma<\/title>\n<meta name=\"description\" content=\"Glycovax Pharma lance la production \u00e0 grande \u00e9chelle d\u2019une CRM197 abordable, conforme aux BPF, pour soutenir les d\u00e9veloppeurs de vaccins humains et animaux.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glycovax Pharma fabrique une prot\u00e9ine CRM197 abordable\" \/>\n<meta property=\"og:description\" content=\"Glycovax Pharma a entrepris la bioproduction \u00e0 grande \u00e9chelle de la prot\u00e9ine porteuse CRM197, destin\u00e9e \u00e0 \u00eatre utilis\u00e9e dans un large \u00e9ventail de vaccins conjugu\u00e9s pour humains et animaux. Les travaux du Conseil national de recherches du Canada (CNRC) ont men\u00e9 au d\u00e9veloppement d\u2019un syst\u00e8me de production unique et hautement efficace pour la CRM197. Glycovax a obtenu une licence du CNRC et a perfectionn\u00e9 le proc\u00e9d\u00e9 afin de r\u00e9pondre aux exigences r\u00e9glementaires et d\u2019atteindre des niveaux de production qui satisfont, \u00e0 un co\u00fbt raisonnable, les besoins du d\u00e9veloppement vaccinal, des entreprises pharmaceutiques et des centres de recherche du secteur, afin de mieux prot\u00e9ger la sant\u00e9 des populations. Les vaccins repr\u00e9sentent la plus importante innovation m\u00e9dicale du XX\u1d49 si\u00e8cle, sauvant chaque ann\u00e9e des millions de vies \u00e0 travers le monde. La pand\u00e9mie de COVID-19 a d\u00e9montr\u00e9 l\u2019importance de pouvoir fabriquer des vaccins efficaces dans notre propre pays afin de lutter contre les infections virales. #glycovaxpharma #espoirtherapeutics #vaccin #conjugu\u00e9 #sant\u00e9CNRC #glycovax\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/\" \/>\n<meta property=\"og:site_name\" content=\"Glycovax Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-09T12:18:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-07T14:31:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/06\/Glycovax-nrc-facebook-v3-fr.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Claude Dagenais\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Claude Dagenais\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/\"},\"author\":{\"name\":\"Claude Dagenais\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#\\\/schema\\\/person\\\/791c61a78825c9dc04135e2ceaca3883\"},\"headline\":\"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable\",\"datePublished\":\"2025-06-09T12:18:40+00:00\",\"dateModified\":\"2025-10-07T14:31:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/\"},\"wordCount\":436,\"publisher\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/glycovax.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Glycovax-nrc-facebook-v3-fr.jpg\",\"articleSection\":[\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/\",\"url\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/\",\"name\":\"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable - Glycovax Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/glycovax.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Glycovax-nrc-facebook-v3-fr.jpg\",\"datePublished\":\"2025-06-09T12:18:40+00:00\",\"dateModified\":\"2025-10-07T14:31:28+00:00\",\"description\":\"Glycovax Pharma lance la production \u00e0 grande \u00e9chelle d\u2019une CRM197 abordable, conforme aux BPF, pour soutenir les d\u00e9veloppeurs de vaccins humains et animaux.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#primaryimage\",\"url\":\"https:\\\/\\\/glycovax.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Glycovax-nrc-facebook-v3-fr.jpg\",\"contentUrl\":\"https:\\\/\\\/glycovax.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Glycovax-nrc-facebook-v3-fr.jpg\",\"width\":1200,\"height\":675,\"caption\":\"Glycovax et le CNRC\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/glycovax-commercialise-un-crm197-abordable\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/\",\"name\":\"Glycovax Pharma\",\"description\":\"Saving millions of lives by using the power of advanced medical nanotechnology.\",\"publisher\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#organization\"},\"alternateName\":\"Glycovax\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#organization\",\"name\":\"Glycovax Pharma\",\"alternateName\":\"Glycovax\",\"url\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/glycovax.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Glycovax-Pharma-carre.png\",\"contentUrl\":\"https:\\\/\\\/glycovax.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Glycovax-Pharma-carre.png\",\"width\":1200,\"height\":1200,\"caption\":\"Glycovax Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/glycovax.com\\\/fr\\\/#\\\/schema\\\/person\\\/791c61a78825c9dc04135e2ceaca3883\",\"name\":\"Claude Dagenais\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4b8cea30a420f348ecee86e20e8aa60d5506584eaad9180873c59b61f2260fe?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4b8cea30a420f348ecee86e20e8aa60d5506584eaad9180873c59b61f2260fe?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4b8cea30a420f348ecee86e20e8aa60d5506584eaad9180873c59b61f2260fe?s=96&d=mm&r=g\",\"caption\":\"Claude Dagenais\"},\"sameAs\":[\"https:\\\/\\\/twohumans.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable - Glycovax Pharma","description":"Glycovax Pharma lance la production \u00e0 grande \u00e9chelle d\u2019une CRM197 abordable, conforme aux BPF, pour soutenir les d\u00e9veloppeurs de vaccins humains et animaux.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/","og_locale":"fr_FR","og_type":"article","og_title":"Glycovax Pharma fabrique une prot\u00e9ine CRM197 abordable","og_description":"Glycovax Pharma a entrepris la bioproduction \u00e0 grande \u00e9chelle de la prot\u00e9ine porteuse CRM197, destin\u00e9e \u00e0 \u00eatre utilis\u00e9e dans un large \u00e9ventail de vaccins conjugu\u00e9s pour humains et animaux. Les travaux du Conseil national de recherches du Canada (CNRC) ont men\u00e9 au d\u00e9veloppement d\u2019un syst\u00e8me de production unique et hautement efficace pour la CRM197. Glycovax a obtenu une licence du CNRC et a perfectionn\u00e9 le proc\u00e9d\u00e9 afin de r\u00e9pondre aux exigences r\u00e9glementaires et d\u2019atteindre des niveaux de production qui satisfont, \u00e0 un co\u00fbt raisonnable, les besoins du d\u00e9veloppement vaccinal, des entreprises pharmaceutiques et des centres de recherche du secteur, afin de mieux prot\u00e9ger la sant\u00e9 des populations. Les vaccins repr\u00e9sentent la plus importante innovation m\u00e9dicale du XX\u1d49 si\u00e8cle, sauvant chaque ann\u00e9e des millions de vies \u00e0 travers le monde. La pand\u00e9mie de COVID-19 a d\u00e9montr\u00e9 l\u2019importance de pouvoir fabriquer des vaccins efficaces dans notre propre pays afin de lutter contre les infections virales. #glycovaxpharma #espoirtherapeutics #vaccin #conjugu\u00e9 #sant\u00e9CNRC #glycovax","og_url":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/","og_site_name":"Glycovax Pharma","article_published_time":"2025-06-09T12:18:40+00:00","article_modified_time":"2025-10-07T14:31:28+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/06\/Glycovax-nrc-facebook-v3-fr.jpg","type":"image\/jpeg"}],"author":"Claude Dagenais","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Claude Dagenais","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#article","isPartOf":{"@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/"},"author":{"name":"Claude Dagenais","@id":"https:\/\/glycovax.com\/fr\/#\/schema\/person\/791c61a78825c9dc04135e2ceaca3883"},"headline":"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable","datePublished":"2025-06-09T12:18:40+00:00","dateModified":"2025-10-07T14:31:28+00:00","mainEntityOfPage":{"@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/"},"wordCount":436,"publisher":{"@id":"https:\/\/glycovax.com\/fr\/#organization"},"image":{"@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#primaryimage"},"thumbnailUrl":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/06\/Glycovax-nrc-facebook-v3-fr.jpg","articleSection":["Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/","url":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/","name":"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable - Glycovax Pharma","isPartOf":{"@id":"https:\/\/glycovax.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#primaryimage"},"image":{"@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#primaryimage"},"thumbnailUrl":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/06\/Glycovax-nrc-facebook-v3-fr.jpg","datePublished":"2025-06-09T12:18:40+00:00","dateModified":"2025-10-07T14:31:28+00:00","description":"Glycovax Pharma lance la production \u00e0 grande \u00e9chelle d\u2019une CRM197 abordable, conforme aux BPF, pour soutenir les d\u00e9veloppeurs de vaccins humains et animaux.","breadcrumb":{"@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#primaryimage","url":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/06\/Glycovax-nrc-facebook-v3-fr.jpg","contentUrl":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/06\/Glycovax-nrc-facebook-v3-fr.jpg","width":1200,"height":675,"caption":"Glycovax et le CNRC"},{"@type":"BreadcrumbList","@id":"https:\/\/glycovax.com\/fr\/glycovax-commercialise-un-crm197-abordable\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glycovax.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Glycovax Pharma commercialise une prot\u00e9ine CRM197 plus abordable"}]},{"@type":"WebSite","@id":"https:\/\/glycovax.com\/fr\/#website","url":"https:\/\/glycovax.com\/fr\/","name":"Glycovax Pharma","description":"Saving millions of lives by using the power of advanced medical nanotechnology.","publisher":{"@id":"https:\/\/glycovax.com\/fr\/#organization"},"alternateName":"Glycovax","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glycovax.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/glycovax.com\/fr\/#organization","name":"Glycovax Pharma","alternateName":"Glycovax","url":"https:\/\/glycovax.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/glycovax.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/04\/Glycovax-Pharma-carre.png","contentUrl":"https:\/\/glycovax.com\/wp-content\/uploads\/2025\/04\/Glycovax-Pharma-carre.png","width":1200,"height":1200,"caption":"Glycovax Pharma"},"image":{"@id":"https:\/\/glycovax.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/glycovax.com\/fr\/#\/schema\/person\/791c61a78825c9dc04135e2ceaca3883","name":"Claude Dagenais","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/f4b8cea30a420f348ecee86e20e8aa60d5506584eaad9180873c59b61f2260fe?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f4b8cea30a420f348ecee86e20e8aa60d5506584eaad9180873c59b61f2260fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f4b8cea30a420f348ecee86e20e8aa60d5506584eaad9180873c59b61f2260fe?s=96&d=mm&r=g","caption":"Claude Dagenais"},"sameAs":["https:\/\/twohumans.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/posts\/2433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/comments?post=2433"}],"version-history":[{"count":9,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/posts\/2433\/revisions"}],"predecessor-version":[{"id":2573,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/posts\/2433\/revisions\/2573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/media\/2489"}],"wp:attachment":[{"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/media?parent=2433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/categories?post=2433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glycovax.com\/fr\/wp-json\/wp\/v2\/tags?post=2433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}